World leader in probiotic products

BioGaia is an innovative Swedish healthcare company and has been a world-leader in dietary supplements with probiotics for nearly 30 years. Over the years we have created networks of leading, independent researchers and specialists, manufacturing experts and local distribution partners worldwide. Our products are recommended by pediatricians and other healthcare professionals in more than 100 countries.

BioGaia’s products contain Lactobacillus reuteri, a probiotic bacteria that helps good microorganisms restore a natural balance in the gut. L. reuteri is one of few bacteria that has co-evolved with humans and because of this it naturally colonizes and has a strong adaptation and interacts with us. To date L. reuteri has been tested in 203 clinical trials (February 2019) and proven effective and safe in children and adults.

BioGaia wants to contribute to better health in the world by offering clinically-proven and user-friendly probiotic products.

Contact us Our products

 

Company presentation

Business mission: BioGaia conducts research and development to offer consumers clinicallyproven, health-promoting, patented and user-friendly probiotic products.

Positioning: Dietary supplements with clinically-tested, high-quality probiotics that are sold through pharmacies and similar retail outlets. In most markets the products are recommended by doctors or other healthcare professionals.

Vision: BioGaia’s vision is to be a ground-breaking leader in probiotics.

Strategy: BioGaia’s strategy is based on five cornerstones: Growth, Customer Focus, Operational Efficiency, Innovation and Sustainability.
Values: My personal commitment is vital for BioGaia’s success. We are innovative and action oriented. We are business minded and deliver on our promises. We are honest, respectful and selfless in what we do and say.

BioGaia’s class B share are listed on the Mid Cap segment of the Nasdaq OMX Nordic Stockholm exchange.

Founded in 1990 by Peter Rothschild and Jan Annwall.

 

Investors

BioGaia’s class B share are listed on the Mid Cap segment of the Nasdaq OMX Nordic Stockholm exchange. Read more

Our business model

Thanks to a successful business model, BioGaia has been able to grow globally with a lean, efficient and agile organization. BioGaia’s business model is based on three external networks – research, production and distribution. Read more

Distribution network

BioGaia's products are sold through around 80 local distribution partners in 100 countries around the world.
Read more

BioGaia's history

BioGaia´s history goes back to the 1980´s, at the time when HIV was discovered. The two scientists Sven Lindgren and Walt Dobrogosz were investigating different probiotics in order to see what effects they had in this area. Read more